Omidubicel, sold under the brand name Omisirge, is a blood-based cell therapy used for the treatment of blood cancers, and severe aplastic anemia. Omidubicel is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.